Alice Natelton's questions to Regeneron Pharmaceuticals Inc (REGN) leadership • Q4 2024
Question
Alice Natelton from Bank of America asked about EYLEA pricing, referencing a source who claimed Regeneron had not improved contract terms to compete with biosimilars, and questioned if the strategy is to hold price.
Answer
EVP of Commercial, Marion McCourt, stated that the company does not comment on pricing strategy.